HIMSS TV
Transform Health Partners' Dr. Peter Billing and Medtronic's George Murgatroyd explain how automated, post-operative videos edited by AI not only enable physicians to enhance patient engagement but can also improve the training of surgeons worldwide.
For Davies Awardee Dr. Robert Jarve and his team from Corewell Health, studying data from a clinic serving high-risk Medicaid patients helped them understand what's driving most of the clinic's ED utilization.
Involving each department across an organization can help healthcare leaders build stronger cyberdefense strategies, says Michael Gross, Cleveland Clinic's manager of cybersecurity intelligence.
Synthetic data supports privacy and early research access – but must meet standards for fidelity, usability and security to earn trust, says Steffen Hess, Health Data Lab head at Germany's Federal Institute for Drugs and Medical Devices (BfArM).
The program provides education and support to new CIOs seeking to drive change in their organizations, says Lateefah Agunbiade of Roanoke Chowan Community Health Center and a recent CIO Connect graduate.
The goals of value-based care are virtually unattainable without alignment of primary and specialty care, hospital and post-acute care, says HSBlox operations chief Lynn Carroll.
The University of Toledo is building and piloting AI models to assist in clinical decision support and to accurately answer patients' and clinicians' questions. Dr. R. Ryan Sadeghian, CMIO and a pediatrician, explains.
AdvancedMD's CEO, Amanda Sharp, explains why a culture of belonging inspires staff before sharing her advice for keeping providers' finances positive in the face of today's cost and reimbursement challenges.
The HIMSS Global Health Conference Education Committee consults attendee feedback and tracks emerging trends to plan its yearly global conference sessions. Committee Chair Michele Krajewski offers a peek inside.
They're used to forecast the longitudinal behavior of trial participants – and by predicting individuals' likely response to a drug, can improve data quality and shorten trial timelines, says Unlearn CEO Steven Herne.